INTERNAL MEDICINE

PUBLICATION record

Abou Mourad, Y., M. Mattar-Muallem, and A. Shamseddine. 2003. Nail toxicity related to Taxane. Dermatol Online J 9 (3): 15.

Abou Mourad, Y., A.Shamseddine, and A. Taher . 2003. Thalidomide-associated gynecomasty in a patient with multiple Myeloma. The Hematol J. 4 (5): 372.

Abou Murad Y, A. Taher, and A..Shamseddine. 2003. Acute tumor lysis syndrome in large B-Cell Non-Hodgkin's Lymphoma induced by steroid and anti CD₂₀. Hematology Journal 4 (3): 222–224.

Aganovic, I, A. S. Ametov, M. Andel, S. T. Azar, F. Bonnici, T. Erbas, N. Hancu, G. Jermendy, R. Lichiardopol, M. Petkova, T. Podar, I. Raz, J. Sieradzki, J. Skrha, G. Soltész, K. Strojek, J. Taton, I. Tkac, and M. Vrtovec. 2003. Clinical management of type-2 diabetes mellitus: Guidelines. Diabetes International Research and Education Cooporation Team Publication.

Aizarani, C., and S. T. Azar. 2002. Hyperlipidemia. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, by G. Hemadeh, 105–114.

Akel, M., and S. T. Azar. 2002. Diabetes. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, by G. Hemadeh, 94–105.

Akel, M., and S. T. Azar. 2002. Obesity. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, by G. Hemadeh, 118–121.

Al Awar, G., and M. Khalife. 2003. Fascioliasis. In Tropical Surgery, ed. R. Kamel and J. S. P. Lumley. Springer-Verlag.

Arnaout, M. S., F. Antoun, and K. Ashkar. 2001. Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia. Human Psychopharmacology-clinical and Experimental 16:279–281.

Arnaout, M. S., and G. W. Jamaleddine. 2001. Rupture of the chordae of the tricuspid valve after knotting of the pulmonary artery catheter. Chest 120:1.

Arnaout, M. S., A. Khalil, and S. Alam. 2003. Influence of angiotensin converting enzymes inhibitors on stable myocardial ischemia in menpausal cardiac patients. International Journal of Clinical and Experimental Obstetrics and Gynaecology XXX (1): 43–46.

Arnulf, B., A. Villemain, C. Nicot, E. Mordelet, P. Charneau, J. Kersual, Y. Zermati, A. Mauviel, A. Bazarbachi, and O. Hermine. 2002. Human T cell lymphotropic virus oncoprotein tax represses TGF-{beta}1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 100:4129–4138.

Ashkar, K., and S. T. Azar. 2002. Thyroid nodule. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, by G. Hemadeh, 61–63.

Ashkar, K., M. Bulbul, A. I. Sharara, M. Hourani, and G. Hamadeh. 2002. Cancer screening for the primary care physician. J Med Lib 49:298–302.

Awar, G., G. Dakdouki, and G. S. Araj. 2002. Buttock abcess brucellosis: Case report and literature review. Journal of Infectious diseases 34 (12): 934–936.

Azar, S. T. 2001. A practical guideline for management of hypertension in patients with diabetes. Leb Med J 48 (6): 392–395.

Azar, S. T., I. Salti, M. S. Zantout, C. H. Shahine, and P. A. Zalloua. 2002. Higher serum leptin levels in females compared to males with type-1 diabetes. Am J Med Sci 323:206–209.

Azar, S. T., and M. S. Zantout. 2001. Evaluation and treatment of obesity. Leb Med J 48 (5): 310–314.

Azar, S. T., and M. S. Zantout. 2001. Management of hirsutism in women of Mediterranean origin. Leb Med J 49:157–160.

Azar, S. T., P. A. Zalloua, R. Medlej, and G. Halabi. 2001. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in Lebanese type-1 diabetics. Endo Res 27:99–108.

Azar, S. T., P. A. Zalloua, M. S. Zantout, C. H. Shahine, and I. Salti. 2002. Leptin levels in patients with type-1 diabetes receiving intensive insulin therapy compared with that in patients receiving conventional insulin therapy. J Endocrinol Invest 25 (8): 724–726.

Barada, K. A., M. I. Kafrouni, C. I. Khoury, N. E. Saade, F. H. Mourad, S. S. Szabo, and C. F. Nassar. 2001. Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. Life Sciences 69:3121–3131.

Bazarbachi, A., and O. Hermine. 2001. Treatment of adult T cell leukemia/lymphoma: Current strategy and future perspectives. Virus Research 78:79–92.

Bilezikian, J. P., J. T. Potts, G. El-Hajj Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S. J. Silverberg, R. Udelsman, and S. A. Wells. 2002. Summary statement from a workshop on aymptomatic hyperparathyrodisim: A perspective for the 21^st century. J Clin Endocrinol Metab 87:353–5361.

Bilezikian, J. P., J. T. Potts, G. El-Hajj Fuleihan, M. Kleerekpor, R. Neer, J. Rastad, S. J. Silverberg, R. Udelsman, and S. A. Wells. 2002. Summary statement from a workshop on aymptomatic hyperparathyrodisim: A perspective for the 21^st century. J Bone Miner Res N2–N11.

Birbari, A. E. 2001. High blood pressure: Definitions, prognostic, and therapeutic implications. Lebanese Med. J. 49:338–341.

Birbari, A. E., and A. Lakiss. 2002. Arterial stiffness. Lebanese Med. J. 50:39–44.

Birjawi, G. A., A. I. Sharara, G. N. Al-Awar, A. N. Tawil, H. Moukaddam, R. A. Khouzami, and M. C. Haddad. 2002. Biliary fascioliasis: Case report and review of the literature. J Med Liban 50:60–2.

Chahal, A., M. Seoud, A. Taher, N. Salem, A. Khalil, and A. Shamseddine. 2002. Endometrial metastasis from signet ring breast carcinoma. Eur J Gynaecol Oncol 23 (6): 563–4.

Chahal, A., A. Taher, and A. Shamseddine. 2002. Sicklemia with multiogram failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin 26 (4): 345–351.

Chahine, C, O. Moukhachen, M. Chedid, G. F. Araj, and A. I. Sharara*. 2001. Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. American Journal of Health-System Pharmacy 58:1819–23. (*Principal and corresponding author.)

Cheha, A., A. I. Sharara, H. Abi Haidar, J. H. Haidar, and A. Bazarbachi. 2002. Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia. J Hepatology 37:163–165. (Letter to the editor)

Chehal, A., J. Haidar, R Jabbour, B. Yamout, and A. Bazarbachi. 2002. Obstructive sleep apnea secondary to chronic lymphocytic leukemia. Annals of Oncology 13:1833. (Letter to the editor)

Chehal, A., A. I. Sharara, J. Haidar, H. Abi Haidar, A. Bazarbachi. 2002. Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia. J Hepatol 37:163–5.

Chehal, A., A. Taher, and A. Shamseddine. 2003. IgM Myeloma and Waldenstrom's macroglobulinemia: A distinct clinical feature, histology, immumophenotype, and chomosomial abnormality. Clin.Lab.Haem 25:187–190.

Dakdouki, G. K., K. H. Obeid, and S. S. Kanj. 2002. Azithromycin-induced rash in a patient with infectious mononucleosis: Case report and review of the literature. Scand J Infect Dis 34:939–41.

Dakik, H. A., and S. Alam. 2001. Myocardial stunning induced and detected by adenosine stress perfusion imaging. Journal of Nuclear Cardiology 8:711–2.

Dakik, H. A., and J. J. Mahmarian. 2003. Thallium-201 reinjection enhances the detection of myocardial ischemia after acute myocardial infarction. Journal of Nuclear Cardiology 10 (2): 117–120.

Dakik, H. A., and A. Nasrallah. 2001. Repeated doses of tissue plasminogen activator for failed thrombolysis. Heart Disease 3:362–364.

Dakik, H. A., I. Salti, R. Haidar, I. Uthman. 2002. Ticlopidine associated with acute arthritis. British Medical Journal 324:27–29.

Darwiche, N., M. El Sabban, R. Bazzi, R. Nasr, S. Hashimi,, O. Hermine, H. de Thé, and A. Bazarbachi. 2001. Retinoic acid dramatically enhances the arsenic trioxide induced cell cycle arrest and apoptosis in retinoic acid receptor a-positive human T-cell lymphotropic virus type-I transformed cells. The Haematology Journal 2:127–135.

El-Sabban, M., R. Abu Merhi, H. Abi Haidar, B. Arnulf, H. Khoury, J. Basbous, J. Nijmeh, H. de Thé, O. Hermine, and A. Bazarbachi. 2002. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 99:3383–89.

El Saghir, N., A. Shamseddine, F. Geara, A. Tawil, A. Taher, Z. Salem, A. Khalil, and M. Seoud. 2002. Age distribution of breast cancer in Lebanon: Analysis of 2282 cases from the American University of Beirut. Leb M.J 50 (1–2): 3–9.

El Sayed, A. M., Z. A. Kanafani, F. H. Mourad, A. M. Soweid, K. A. Barada, C. S. Adorian, W. A. Nasreddine, and A. I. Sharara. 2003. A randomized single-blind trial of whole versus split-dose polyethylene glycol electrolyte solution for colonoscopy preparation. Gastrointest Endosc 58 (1): 36–40.

El-Ali, H., A. Abu Yabis, E. Issa, Z. Salem, A. Tawil, N. Khoury, and G. El-Hajj Fuleihan*. 2002. Hypercalcemia in Langerhan cell granulomatosis with elevated calcitriol levels. Bone 30:331–334. (*Senior author.)

El-Hajj Fuleihan, G. 2002. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 17 (supllement 2): N51–N56.

El-Hajj Fuleihan, G., R. Baddoura, H. Awada, P. Rizk, and M. McClung. 2002. Lebanese guidelines for osteoporosis assessment and treatment. Lebanese Medical Journal.

El-Hajj Fuleihan, G., R. Baddoura, H. Awada, N. Salam, M. Salamoun, and P. Rizk. 2002. Low peak bone mineral density in healthy Lebanese subjects. Bone 31:520–8.

El-Hajj Fuleihan, G., E. M. Brown, and H. Heath III. 2002. The familial benign hypocalciuric hypercalcemic syndromes. In Principles of Bone Biology, ed. J. P. Bilezikian, L. G. Raisz, and G. A. Rodan. San Diego, CA: Academic Press.

El-Hajj Fuleihan, G., and H. Heath III. 2001. Familial benign hypocalciuric hypercalcemia. In The Parathyroids: Basic and Clinical Concepts, ed. J. P. Bilezikian, R. Marcus, and M. A. Levine. San Diego, CA: Academic Press.

El-Hajj Fuleihan, G., M. Nabulsi, M. Shoucair, M. Salamoun, C. Hajj-Shahine, A. Kizirian, and R. Tannous. Hypovitaminosis D in healthy school children. Pediatrics 107:1–7.

El-Hajj Fuleihan, G., J. Stock, G. Saifi, and M. McClung. 2002. Bone density reporting in the United States: A national survey. J Clin Dens 5 (1): 3–9.

El-Sayyed, A. M. A., and S. I. Sharara. 2001. Hepatitis C. J Med Lib 49 (2): 71–7.

Farah, S., A. Abyad, F. H. Mourad, and S. Uthman. 2001. Lynch syndrome: Report of two families from Lebanon and clinical review. Emirates Medical Journal 19:181–185.

Farhat, G., B. Yamout, M. A. Mikati, S. Demirjian, R. Sawaya, and G. El-Hajj Fuleihan*. 2002. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:1348–1353. (*Senior author.)

Haidar, J., A. Bazarbachi, R. Mahfouz, H. Abi Haidar, H. Jaafar, and R. Daher. 2002. Serum Flt-3 ligand variation as predictive indicator of hematopoietic stem cell mobilization. J Hematother Stem Cell Res. 11:533–8.

Haidar, J. H., A. Bazarbachi, M. R. Nasr, M. E. El-Sabban, and R. Daher. 2003. Signet ring-like light chain myeloma with systemic spread. Eur. J. Haem. 70:249–50.

Haidar, J. H., A. Shamseddine, Z. Salem, Y. Abu Murad, M. R. Nasr, G. Zaatari, and A. Bazarbachi. 2003. Loss of CD₂₀ expression in relapsed lymphoma after rituximab therapy. Eu J Haematol 70 (5): 330–2.

Hannoush, H., K. Shaar, S. Alam, A. Nasrallah, J. Sawaya, and H. A. Dakik. 2003. Analysis of referral patterns, predictive accuracy, and impact of myocardial perfusion imaging on patient management in a new nuclear cardiology laboratory. Journal of Nuclear Cardiology 10 (2): 148–153.

Hermine, O., I. Allard, V. Levy, B. Arnulf, A. Gessain, and A. Bazarbachi. 2002. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. The Haematology Journal 6:276–282.

Hicken, B. L., A. I. Sharara, G. A. Abrams, M. Eloubeidi, M. B. Fallon, and M. R. Arguedas. 2003. HVPG measurements to assess response to primary prophylaxis in patients with cirrhosis: A decision analytic study. Aliment Pharmacol Ther 17:145–153.

Issa, I., and F. H. Mourad. 2001. Hepatitis A: An updated overview. Leb Med J 49 (2): 61–65.

Jabr, F., A. Shamseddine, I. Uthman, A. Chehal, and A. Taher. 2003. Thrombotic thrombocytopenic purpura in a patient with Behcet’s disease. Arthritis & Rheumatism. 48:1468–1469.

Kanafani, Z. A., A. Ghossain, A. I. Sharara, J. Hatem, and S. S. Kanj. 2003. Endemic gastrointestinal anthrax in 1960s Lebanon: Clinical manifestations and surgical findings. Emerg Infect Dis 9:520–5.

Kanafani, Z. A., T. H. Mahfouz, and S. S. Kanj. 2002. Infective endocarditis at a tertiary care centre in Lebanon: Predominance of streptococcal infection. J Infect 45:152–9.

Kanj, S. S., N. Adel, and G. F. Araj. 2001. The continued prevalence of gram-negative infections in febrile neutropenic patients in Lebanon. Comparison with studies from the Middle East. BMJ MEA 8:6–13.

Kanj, S. S., S. S. Amr, and G. D. Roberts. 2001. Ramichloridium mackenziei brain abscess: Report of two cases and review of the literature. Med Mycol 39:97–102.

Kanj, S. S., G. F. Araj, A. Taher, and L. B. Reller. 2001. Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literature. Clin Microbiol Infect 7:510–3.

Kanj, S. S., M. Chedid, and G. F. Araj. 2001. Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon. J Med Liban 49:13–7.

Kanj, S. S., and D. J. Sexton. 2002. Other Pseudomonas aeruginosa infections. In UpToDate, ed. B. D. Rose. Wellesley, MA: UpToDate.

. 2002. Pseudomonas aeruginosa pneumonia. In UpToDate, ed. B. D. Rose. Wellesley, MA: UpToDate.

. 2002. Pseudomonas aeruginosa skin, soft tissue and bone infections. In UpToDate, ed. B. D. Rose. Wellesley, MA: UpToDate.

. 2002. Pseudomonas bacteremia and endocarditis. In UpToDate, ed. B. D. Rose. Wellesley, MA: UpToDate.

Khalife, M., and G. Al Awar. 2003. Pentastomiasis and halzoun or marrara. In Tropical Surgery, ed. R. Kamel and J. S. P. Lumley. Springer-Verlag.

Khalifeh, M., F. H. Mourad, and A. Al-Kutoubi. 2003. Percutaneous hepaticojejunostomy with use of a metal stent for injury of the right hepatic duct after laparoscopic cholecystectomy. J Vasc Interv Radiol 14 (4): 509–12.

Khater, B., and S. T. Azar. 2002. Amenorrhea. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, ed. G Hemadeh, 128–130.

. 2002. Menopause, hormone replacement and osteoporosis. In Practical Clinical Guide for Lebanese Primary Care Health Center Physicians, ed. G Hemadeh, 139–143.

Krikorian, A., A. I. Sharara*, and R. Khalifeh. 2002. Valproic acid-associated hyperammonemic encephalopathy. J Pharm Technol 18:70–4.

Lee, J. R., Z. X. He, H. A. Dakik, and M. S. Verani. 2001. Myocardial perfusion and angiographic correlations in patients with ST-segment elevation during dobutamine stress perfusion imaging. Journal of Nuclear Cardiology 8:365–70.

Major, S., N. Pashayan, S. Atweh, R. Chidiac-Tannoury, S. Shaar, I. Uthman, A. F. Masri, and T. Arayssi. 2002. Practice patterns of antiphospholipid syndrome at a tertiary teaching hospital in Lebanon. Lupus 11 (11): 759–764.

Makhlouf-Akel, M., and I. Salti. 2001. Management of dyslipidemia. Leb Med J 49:274–278.

Melby, J. C., and S. T. Azar. 2001. Hypoaldosteronism and mineralocorticoid resistance. In De Groot Textbook of Endocrinology, 4th ed, 1845–1850.

Mooty, M. Y., S. S. Kanj, G. F. Araj, and R. R. Khalifeh. 2001. Clinical microbiological case: A previously healthy woman presenting with headache and diplopia. Clin Microbiol Infect 7:498, 517–9.

Mooty, M. Y., S. S. Kanj, M. Y. Obeid, G. Y. Hassan, and G. F. Araj. 2001. A case of Trichosporon beigelii endocarditis. Eur J Clin Microbiol Infect Dis 20:139–42.

Moukarbel, G. V., M. S. Arnaout, and S. E. Alam. 2001. C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina. Clinical Cardiology 24:506–510.

Moukarbel, G. V., and H. A. Dakik. 2003. Diffuse coronary artery spasm induced by guidewire insertion. Journal of Invasive Cardiology 15 (6): 353–354.

Mourad, F. H., K. A. Barada, N. Abdel-Malak, N. A. Bou Rached, C. I. Khoury, N. E. Saade, and C. F. Nassar. 2003. Interplay between nitric oxide and vasoactive intestinal polypeptide in inducing fluid secretion in rat jejunum. J Physiol 550.3:863–871.

Mourad, F. H., H. Hannoush, M. Bahlawan, I. Uthman, and S. Uthman. 2001. Panniculitis and arthritis as the presenting manifestation of chronic pancreatitis. J Clin Gastroenterol 32 (3): 259–261.

Mourad, F. H., A. V. Hoffbrand, M. Sheikh-Taha, S. Koussa, A. I. Khoriaty, and A. Taher. 2003. Comparison between desferrioxamine and a combined therapy of desferrioxamine with deferiprone in iron overloaded thalassemia patients. Br J Haematology 121 (1): 187–189.

Mourad, F. H., M. Khalifeh, A. Al-Kutoubi, and I. Khalil. 2001. Inferior vena cava obstruction in Budd-Chiari syndrome: Successful treatment by radiologic stenting followed by a portosystemic shunt. Eur J Gastroenterol Hepatol 13:275–278.

Musharafieh, U., N. Nassar, and S. T. Azar*. 2002. Acute suppurative thyroiditis: A forgotten entity: Case report and literature review. The Endocrinologist 12:173–177.

Muwakkit, S., R. Rachid, A. Bazarbachi, T. Araysi, and G. Dbaibo. Treatment resistant infantile Evans syndrome. 2001. Pediatrics International. 43: 502–504.

Nasr, R., A. Rosenwald, M. E. El-Sabban, B. Arnulf, P. Zalloua, Y. Lepelletier, F. Bex, O. Hermine, H. Staudt de Thé, and A.  Bazarbachi. 2003. Arsenic/interferon specifically reverses two distinct gene networks critical for the survival of HTLV-I infected leukemic cells. Blood 101:4576–82.

Palmer, S. M., R. H. Drew, J. D. Whitehouse, V. F. Tapson, R. D. Davis, R. R. McConnell, S. S. Kanj, and J. R. Perfect. 2001. Safety of aerosolized amphotericin B lipid complex in lung transplant patients. Transplantation 72:545–8.

Raynauld, J. P., C. Buckland-Wright, R. Ward, D. Choquette, B. Haraoui, J. Martel-Pelletier, I. Uthman, V. Khy, J. L. Tremblay, C. Bertrand, and J. P. Pelletier. 2003. Safety and efficacy of intra-articular steroid injections on the progression of knee osteoarthritis: A randomized double-blind, placebo-controlled trial. Arthritis & Rheumatism. 48 (2): 370–377.

Saliba, N., S. T. Azar, E. Gharios, G. Halaby, R. Medlej, C. Saab, I. Salti, M. Sandid, and the Diabetes Advisory Board. 2001. National diabetes medical guidelines. WHO-National Non-Communicable Diseases Program Publication 2001.

Salti, I. S. 2002. Post-menopausal hormone replacement re-visited. B Med J -Middle East 9:6.

Seoud, M., N. El Saghir, A. Shamseddine, Z. Salem, J. Awwad, and A. Khalil. 2001. Tamoxifen and ovarian pathologies: A prospective study. European Journal of Obst and Gyn and reproductive Biology 100:77–80.

Seoud, M., F. B. Geara, A. Shamseddine, Z. Salem, and A. Khalil. 2003. Short duration neoadjuvant chemotherapy followed by Radiotherapy for advanced carcinoma of the cervix: Results and prognostic variables. Eur J Gyn Oncol 24 (2): 163–168.

Seoud, M. A., S. S. Kanj, M. Habli, G. F. Araj, and A. M. Khalil. 2003. Brucella pelvic tubo-ovarian abscess mimicking a pelvic malignancy. Scand J Infect Dis 35:277–8.

Seoud, M., A., Nassar, I. Usta, M. Mansour, I. S. Salti, and K. Younes. 2003. Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester. Am J Perintology 20:59–62.

Shamseddine, A., A. Taher, Y.Abou-Mourad, M. Seoud and A. Khalil. 2003. Cure of metastatic uterine Carcinosarcoma to lungs. Int. J Gynecol Cancer 13:1–2.

Sharara, A. I., G. Abi-Saad, M. Haddad, A. Mansour, and A. Tawil. 2001. Acute schistosomal granulomatous cholecystitis. Eur J Gastroenterol Hepatol 13:1001–3.

Sharara, A. I., M. Chedid, G. A. Araj, K. A. Barada, and H. Mourad. 2002. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, and tetracycline in Lebanon. Int J Antimicrob Agents 19:155–8.

Sharara, A. I., I. S. Dandan, and M. Khalifeh. 2001. Living-related donor transplantation other than kidney. Transplantation Proceedings 33:2745–6.

Sharara, A. I., and M. Eloubeidi. 2002. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. (Invited editorial.) Gastrointest Endosc 55:761–4.

Sharara, A. I.*, A-L Hamdan*, A. Younes, and N. Fuleihan. 2001. Effect of short-term aggressive therapy on Laryngeal symptoms and voice characteristics in patients with Gastroesophageal reflux. Acta Otolaryngologica 121 (7): 868–72. (*Both are first authors and contributed equally to all aspects of manuscript.)

Sharara, A. I., M. Khalifeh, C. Yaghi, R. Noun, R. Sayegh, and G. Khoury. 2001. Update on the status of liver transplantation in Lebanon. J Med Lib 49 (2): 1117–20.

Sharara, A. I., and D. C. Rockey. 2001. Gastroesophageal variceal hemorrhage. New England Journal of Medicine 345 (9): 669–81.

. 2002. Pyogenic liver abscess. Curr Treat Opinion Gastroenterol 5:437–442.

. 2003. Therapy for primary prophylaxis of varices: And, the winner is…? Hepatology 37:473–5 (editorial).

Sharara, A. I., M. Shedid, G. F. Araj, K. A. Barada, and F. H. Mourad. 2002. Prevalence of helicobacter pylori resistance to metronidazole, clarithromycin, and tetracycline in Lebanon. Int J Antimicrob Agents 19 (2): 155–158.

Shbaklo, H., S. T. Azar, H. Terwedow, G. Halaby, R. P. Naja, and P. A. Zalloua. 2003. No association between the 1031 polymorphism in the TNF-α promoter region and type-1 diabetes. Hum Immunol 64 (6): 633–638.

Taher, A., I. Khalil, R. Abou-Merhi, A. Shamseddine, and A. Bazarbachi. 2003. High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon. Thrombosis and Haemostasis 89:945–6. (Letter to the editor)

Taher, A., I. Khalil, A. Shamseddine, F. El-Ahdab, and A. Bazarbachi. 2001. High prevalence of factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is Eastern Mediterranean region the primary focus of this mutation? Thrombosis and Haemostasis 86:723–4. (Letter to the editor)

Taher, A., Y. Abou-Murad , A. Abchee, P. Zalouaa, and A. Shamseddine. 2002. Pulmonary thromboembolism in beter-thalassemia intermedia: Are we aware of this complication? Hemoglobine 26 (2): 107–12.

Taher, A., R. Badreddine, J. Deeb, and I. Uthman. 2002. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis & Rheumatism 46 (5): 1410.

Taher, A., I. Khalil, R. Abou Merhi, A. Shamseddine, and A. Bazarbachi. 2003. High prevalence of prothrombin G 20210A mutation among patients with deep venous thrombosis in Lebanon. Thromb Haemost 89 (5): 945–6.

Taher, A., I. Khalil, A. Shamseddine, F. El-Ahdab, and A. Bazarbachi. 2001. High prevelance of factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is the eastern Mediterranean region the area of origin of this mutation. Thromb Haemost 86 (2): 723–4.

Taher, A., M. Sheikh-Taha, S. Koussa, A. Inati, R. Neeman, and F. H. Mourad. 2001. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients. Eur J Haematology 67:30–34.

Uthman, I., A. Al-Kutoubi, and J. Sawaya. 2001. Recurrent venous thrombosis in Behcet’s disease: Successful endovascular treatment with thrombolysis and stent. Clinical Rheumatology 20 (4): 267–9.

Uthman, I., A. R. Bizri, and M. Khalifeh. 2002. Peritoneal sarcoidosis. Seminars in Arthritis & Rheumatism 31 (5): 353.

Uthman, I., H. Dakik, I. Salti, and R. Haidar. 2002. Authors' refute careless talk about ADP receptor antagonists. BMJ 325 (7371): 1036.

Uthman, I., and A. E. Gharavi. 2002. Viral infections and antiphospholipid antibodies. Seminars in Arthritis & Rheumatism 31 (4): 256–263.

Uthman, I., R. Hajj-Ali, T. Arayssi, A. F. Masri, and F. Nasr. 2001. The arthritis of familial Mediterranean fever. Rheumatology International 20 (4): 145–148.

Uthman, I., I. Khalil, A. Taher, A. R. Bizri, and A. E. Gharavi. 2002. Catastrophic antiphospholipid syndrome associated with typhoid fever. Arthritis & Rheumatism 46 (3): 850.

Uthman, I., A. Muffarij, W. Mudawar, F. Nasr, and A. F. Masri. 2001. Lupus nephritis in Lebanon. Lupus 10 (5): 378–381.

Uthman, I., D. M. Najjar, S. S., Kanj, and Z. Bashshur. 2003. Anticardiolipin antibodies in acute multifocal posterior placoid pigment epitheliopathy. Ann Rheum Dis 62:687–8.

Uthman, I., J. P. Raynauld, and B. Haraoui.2003. Intra-articular therapy in Osteoarthritis. Postgraduate Medical Journal 79:449–453.

Uthman, I., A. Taher, and I. Khalil. 2001. Hughes syndrome associated with varicella infection. Rheumatology International 20 (4): 167–168.

Younis, H., G. Farhat, and G. El-Hajj Fuleihan. 2002. Efficacy and tolerability of cyclical intravenous pamidronate in patients with low bone mass. J Clin Dens 5 (2): 1–7.

Zahed, L., F. H. Mourad, R. Alameddine, S. Aoun, S. Koussa, and A. Taher. 2002. Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassemia patients. Haematologia 31 (4): 333–339.

Zalloua, P. A., H. Shbaklo, G. Halby, H. Terwedow, X. Xu, and S. T. Azar*. 2002. Type- 2 diabetes family history delays the onset of type-1 diabetes. J Clin Endocrinol Metab 87:3192–3196.

Zalloua, P. A., H. Terwedow, H. Shbaklo, G. Halaby, X. Xu, and S. T. Azar*. 2003. Host and environmental factors defining the epidemiology of type 1 diabetes mellitus in a group of Lebanese children and young adults. J Pediatr Endocrinol Metab 16 (5): 759–69.

Zantout, H., and K. A. Barada. 2001. Nonalcoholic steatohepatitis. J Med Lib 49 (2): 90–93.

Zayour, D., S. T. Azar*, N. Azar, M. Nasser, M. Obeid, M. Salman, G. S. Dbaibo, and F. F. Bitar. 2003. Endocrine changes in a rat model of chronic hypoxia mimicking cyanotic heart disease. Endo Res 29 (2): 191–200.

Abstracts, Conferences, and Proceedings

Arabi, A., M. Choucair, M. Nabulsi, J. Maalouf, L. Dib, R. Veith, and G. El-Hajj Fuleihan*. 2003. Lean mass as a major determinant of bone mass in puberty. 5^th International Symposium on Nutritional Aspects of Osteoporosis, Lausanne, Switzerland, May 14–17, 2003.

Arayssi, T., R. Hamra, S. Awwad, I. Kazma, F. Homaidan, I. Uthman, and Z. Bashour. 2002. Treatment of refractory posterior vitritis in Behçet disease with infliximab. Proceedings of the 66th Annual meeting of the American College of Rheumatology. New Orleans, Louisiana, Unites States.

Arnulf, B., A. Villemain, C. Nicot, P. Charneau, J. Kersual, Y. Zermati, M. Derkinderen, F. Bex, A. Bazarbachi, and O. Hermine. 2001. Human T cell lymphotropic virus oncoprotein tax represses TGF-b1 signaling in human T-cells via c-jun activation: A potential mechanism of HTLV-I leukemogenesis. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland. Aids. Res. Hum. Retrovirus. 17:S24.

Azar, S. T. 2002. Advances in understanding type-1 diabetes in Lebanon. Presented at the III Pan Arab Congress on Diabetes and Endocrinology. Tunis, Tunisia, October 2002.

. 2003. New strategies in diabetes. Presented at the 3rd Regional Conference on the Treatment of type 2 Diabetes Mellitus, Budapest, Hungary, May 2003.

. 2003. Osteoporosis and bone markers. Presented at Update in Women’s Health Symposium, Jeddah, Saudi Arabia, January 2003.

. 2003. Osteoporosis treatment modalities. Presented at Update in Women’s Health Symposium, Jeddah, Saudi Arabia, January 2003.

Barada, K. A., F. H. Mourad, F. H. Homeidan, C. Khoury, and C. F. Nassar. 2001. Effect of experimental diabetes on taurine transport in the rat intestine. Gut 49 (suppl 3): A2222.

Bashshur, Z., A. Taher, D. Najjar, T. K. Arayssi, A. Shamseddine, and B. Noureddine. 2002. Retinol vein occlusion and anticardiolipin antibodies: A prospective study in patients without factors. XVI Meeting of the international Society of Haematology, Cairo. (Poster-PF 9/6)

Bazarbachi, A., R. Abou Merhi, A. Gessain, H. Khoury, O. Gout, H. Abi Haidar, H. De Thé, O. Hermine, and M. El-Sabban. 2002. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. 7th Congress of the European Haematology Association. Florence Italy. The Haematology Journal.

Bazarbachi, A., R. Abou Merhi, A. Gessain, H. Khoury, R. Talhouk, R. Nasr, O. Gout, R. Sulaihan, F. Homaidan, H. de Thé, O. Hermine, and M. El-Sabban. 2003.  HTLV-I infected cells extravasate through the endothelial barrier using a local angiogenesis-like mechanism: Implications for invasion and metastasis. 8th Congress of the European Haematology Association, Lyon, France. The Haematology Journal. 4s2: 22–23.

Bazarbachi, A., R. Abou Merhi, R. Nasr, A. Gessain, O. Gout, H. de Thé, O. Hermine, and M. El-Sabban. 2003. HTLV-I infected cells extravasate through the endothelial barrier using a local angiogenesis-like mechanism: implications for invasion and metastasis. 11^th International Conference on Human Retrovirology: HTLV and related viruses, San Francisco, USA. Aids. Res. Hum. Retrovirus. 19:S16.

Bazarbachi, A., and O. Hermine. 2001. Treatment of adult T cell leukemia/lymphoma: Current strategy and future perspectives. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland. Aids. Res. Hum. Retrovirus. 17:S28.

Bazarbachi, A., R .Nasr, M. El Sabban, O. Hermine, and H. de Thé. 2001. Arsenic/interferon-triggered apoptosis in HTLV-I transformed cells is associated with proteasome mediated tax degradation and reversal of NF-kB activation. Joint International Congress on APL and Differentiation Therapy, Rome, Italy.

Bazarbachi, A.,  R. Nasr, A. Rosenwald, M. El-Sabban, R. Merat, F. Bex, O. Hermine, L. Staudt, and H. de Thé. 2002. Arsenic trioxide and interferon alpha induce proteasome-mediated tax degradation and selectively downregulate the transcription of NF-kappaB target genes in human T cell lymphotropic virus transformed cells. 7th Congress of the European Haematology Association, Florence, Italy. The Haematology Journal.

Birbari, A., A. Lakiss, and S. Arnaout. 2003. C-Reactive protein in mild untreated essential hypertension. European Council of Cardiovascular Research.

Birbari, A., A. Lakiss, S. Arnaout, and S. Mallat. 2003. Arterial dynamics: Relationship between sphygmocardiography and CR-2000 cardiovascular profile in mild essential hypertension. Third International Workshop on “Clinical Autonomic Research.” Vol-13,1:68.

Bikhazi, A. B., M. Khalifeh, A Al-Kutoubi, J. Abbas, F. Mourad, A. Chehal, M. Z. Habbal, and A. Shamseddine. 2002. Comparative pharmacokinetics between intravenous and intra-arterial delivery of Gemcitabine in unresectable pancreatic cancer patients. AAPSPharmSci 4:W5224.

Birbari, A. E., H. Haddad, A. Lakiss, and N. Daouk. 2002. Correlated of increased renal resistive index in untreated mild essential hypertension. 7^th Congress of Arab Society of Nephrology and Renal Transplantation. Abstract, p. 148.

Birbari, A. E., A. Lakiss, S. Arnaout, and S. Mallat. 2003. Arterial dynamics: Relationship between sphygmocardiography and CR-2000 cardiovascular profile in mild essential hypertension. Clinical Autonomic Research 13:68.

Birbari , A. E., S. Mallat, A. Lakiss, and N. Daouk. 2002. Obesity hypertension vs. lean hypertension: Similarities and contrasts. 11^th International Congress on Cardiovascular Pharmacotherapy. Cardiovascular drugs and therapy abstract book,  # 354.

Darwiche, N., A. Hatoum, R. Nasr, G. Abou-Lteif, and A. Bazarbachi. 2002.  N-(4-Hydroxyphenyl) retinamide (HPR) induces apoptosis and growth inhibition in malignant but not normal T lymphocytes at clinically achievable concentrations. American Association for Cancer Research Special Meeting "Apoptosis and Cancer: Basic Mechanisms and Therapeutic Opportunities in the Post-Genomic Era," Waikoloa, Hawaii.

Eid-Fares, J., M. Choucair, M. Nabulsi, M. Salamoun, M. Hajj-Shahine, and G. El-Hajj Fuleihan*. 2002. Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodeling. Second International Conference on Children’s Bone Health, Sheffield, Calcified Tissue International 2002; 70 (5): Abstract 28, p. 369. (*Senior author.)

El Sabban, M., R. Abou-Merhi, H. Abi-Haidar, B. Arnulf, J. Basbous, H. Khoury, J. Nijmeh, O. Hermine, and A. Bazarbachi. 2001. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and communicate with endothelial cells through gap junctions. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland.

El-Sabban, M., R. Abou Merhi, A. Gessain, B. Arnulf, H. Khoury, O. Gout, H. Abi Haidar, H. de Thé, O. Hermine, and A. Bazarbachi. 2002. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. HTLV European Research Network, general meeting, Berlin, Germany.

. 2002. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. American Society of Hematology, Philadelphia, USA. Blood 100:727a.

El-Saghir, N., Y. Abou Mrad, J. Abbas, A. Mufarrij, A. Shamseddine, and Z. Salem. 2003. Dexrazoxane is an effective immediate therapy in doxorubicin extravagation. Proceedings of American Society of Clinical Oncology (ASCO) 22: Abstract 580.

El-Hajj Fuleihan, G., M. Badra, A. Tayim, M. Makari, M. Salamoun, N. Afeiche, O. Baddoura, S. Boulos, R. Haidar, S. Lakkis, R. Musharrafieh, A. Nsouli, and A Taha. 2001. Lebanese patients with hip fractures are relatively young, but have osteoporosis. J Bone Miner Res 2001 Suppl 1: Abstract M 337.

El-Hajj Fuleihan, G., M. Badra, A. Tayim, N. Salamoun, N. Afeiche, O. Baddoura, R. Boulos, R. Haidar, S. Lakkis, R. Musharrafieh, A. Nsouli, A. Taha, and G. Makari. 2002. Total body fat as a predictor of hip fracture. J Bone Mineral Res 2002 Supl (1): Abstract 1393.

El-Hajj Fuleihan, G., D. Zayour, M. Daouk, W. Medawar, and M. Salamoun. 2002. Predictors of bone mineral density in dialysis. J Bone Mineral Res 2002 Supl (1): Abstract M 337.

Hermine, O., and A. Bazarbachi. 2001. Treatment of adult T cell leukemia/lymphoma: Clinical results of new therapeutic approaches. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland. Aids. Res. Hum. Retrovirus. 17:S28.

Hwalla, N., N. Torbay, L. Shaker, S. Azar, and Z. Habbal. 2002. Postprandial substrate utilization in obese insulin resistant subjects in response to high carbohydrate vs high protein meals. Presented at the Ninth International Congress on Obesity, Sao Paulo, Brazil. Int J Obesity 26, suppl (1): S 94.

Kanafani, Z. A., and S. S. Kanj. 2002. A patient with intestinal anthrax. Presented at the 40^th Annual Meeting of the Infectious Diseases Society of America, Chicago, IL, October 2002.

Lepelletier, Y., I. C. Moura, B. Arnulf, P. England, C. Beaumont, A. Bazarbachi, P. J. Bjorkman, R. Monteiro, and O. Hermine. 2003. A new neutralizing monoclonal antibody (MAB A24) directed against the transferring receptor inhibits the proliferation of T lymphocytes from ATL patients. 11^th International Conference on Human Retrovirology: HTLV and related viruses, San Francisco, USA. Aids. Res. Hum. Retrovirus. 19:S45.

Mourad, F. H., N. Abdel Malak, K. Barada, F. Homeidan, C. Khoury, and C. F. Nassar. 2001. Involvement of nitric oxide (NO) in vasoactive intestinal polypeptide (VIP)-induced fluid secretion in rat jejunum. Gut 49 (suppl 3): A2276.

Mourad, F. H., N. Abou Rashed, K. Barada, F. Homeidan, and C. F. Nassar. 2001. Inhibitory effect of chemical colitis on jejunal water absorption: role of vasoactive intestinal polypeptide (VIP) and nitric oxide. Gut 49 (suppl 3): A1178.

Nabulsi, M., C. Salibi, G. Araj, and the Lebanese Collaborative Hepatitis B Study Group. 2003. Prevalence of Hepatitis B infection in Lebanon. Presented at the 2003 Southern Regional Meetings, New Orleans, Louisiana, February 2003.

Nasr, R., M. El Sabban, J. Basbous, R. Abou-Merhi, F. Bex, O. Hermine, H. de Thé, and A. Bazarbachi. 2001. Arsenic/interferon-triggered apoptosis in HTLV-I transformed cells is associated with proteasome mediated Tax degradation and reversal of NF-kB activation. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland. Aids. Res. Hum. Retrovirus. 17:S50.

Nasr, R., N. Darwiche, H. de Thé, and A. Bazarbachi. 2001. Retinoic acid increases retinoid X receptor DNA binding activity despite the degradation of retinoid receptor proteins in HTLV-I transformed cells. 10^th International Conference on Human Retrovirology: HTLV and related viruses, Dublin, Ireland. Aids. Res. Hum. Retrovirus. 17:S55.

Nasr, R., A. Rosenwald, M. El-Sabban, B. Arnulf, Y. Lepelletier, F. Bex, O. Hermine, L. Staudt, H. de Thé, and A. Bazarbachi. 2002. Arsenic/interferon specifically reverses two distinct gene networks critical for the survival of HTLV-I infected leukemic cells. American Society of Hematology, Philadelphia, USA. Blood 100:215b.

. 2003. Arsenic/interferon specifically reverses two distinct gene networks critical for the survival of HTLV-I infected leukemic cells. 8th Congress of the European Haematology Association, Lyon, France. The Haematology Journal 4s2:134–135.

Nasr, R., A. Rosenwald, M. El-Sabban, F. Bex, B. Arnulf, O. Hermine, L Staudt, H. de Thé, and A. Bazarbachi. 2002. Arsenic trioxide and interferon alpha induce proteasome-mediated tax degradation and selectively downregulate the transcription of NF-kappaB target genes in human T cell lymphotropic virus transformed cells. HTLV European Research Network, general meeting, Berlin, Germany.

Nasr, R., A. Rosenwald, M. El-Sabban, O. Hermine, L. Bex Staudt, H. de Thé, and A. Bazarbachi. 2003. Arsenic/interferon specifically reverses two distinct gene networks critical for the survival of HTLV-I infected leukemic cells. 11^th International Conference on Human Retrovirology: HTLV and related viruses, San Francisco, USA. Aids. Res. Hum. Retrovirus. 19:S52.

Salem, Z., P. A. Zalloua, A. Chehal, N. Bitar, M. Abboud, A. Kadri, B. Chami, and A. Bazarbachi. 2003. Effective treatment of hypereosinophilic syndrome with imatinib mesylate. 8th Congress of the European Haematology Association. Lyon, France. The Haematology Journal 4s2:170.

Samaha, J., S. S. Kanj, and G. F. Araj. 2003. In vitro activity of various antimicrobial agents against extended-spectrum beta-lactamase producing Klebsiella pneumoniae and Escherichia coli. Presented at the 103^rd American Society for Microbiology General Meeting, Washington DC, May 2003.

Seoud, M., J. Abbas, M. Khalil, M. Charafeddine, Z. Salem, N. El Saghir, F.Geara, and A. Shamseddine. 2003. Clinical characteristics of breast cancer patients diagnosed and/or treated at the American University of Beirut Medical Center (AUBMC) from 1990 to 2001. Proceedings of the American Society of Clinical Oncology (ASCO) 22: Abstract 341.

Sexton, D. J., L. Olaison, C. H. Cabell, A. Chen, D. Durack, L. Clara, S. S. Kanj, A. Ramos, M. Sanchez, M. Stryjewski, A. Wang, C. Mestres, A. Street, and E. Abrutyn for the ICE Investigators. 2003. The influence of referral on the clinical spectrum of infective endocarditis: A prospective study of 1014 case of definite endocarditis from the International Collaboration on Endocarditis (ICE). Presented at the 7^th International Society of Cardiovascular Infectious Diseases Meeting, Chamonix, France, June 2003.

Shamseddine, A., A. El Koutoubi, A. Chehal, A. Taher, A. Bikhazi, F.Mourad, J.Abbas, and M. Khalifeh. 2003. A phase I/II clinical and pharmacokinetics study of intra-arterial gemcitabine (dfdc) with selective emboligation in locally advanced and regionally metastatic pancreatic carcinomas. Proceedings of the American Society of Clinical Oncology (ASCO) 22: Abstract: 1320.

Shamseddine, A., A. El Kutoubi, A. Chehal, A. Taher, A. Bikhazi, F. Mourad, J.Abbas, and M. Khalifeh. 2003. Pharmacokinetics differences between intravenous and intra-arterial delivery of Gemcitabine in unresectable pncreatic cancer patients with initial clinical data. Oral presentation, session on Regional Tumor Treatment of ISRCT on the 14^th International Congress on Anti-Cancer Treatment ICACT, Paris.

Shamseddine, A., A. Sibai, N. Gehchan, B. Rahal, N. El Saghir, N. Ghosn, G. Aftimos, N. Chamseddine, and M. Seoud. 2002. Cancer incidence in post war Lebanon: The first population-based estimates 1993 and 1998. Oral presentation at The IV^th Annual Meeting of the Lebanese Society of Medical Oncology (LSMO4). Beirut, Lebanon , Sept. 26–28, 2002.

Shamseddine, A., A. Taher, N. El Saghir, Z. Salem, A. Chehal, R. Jalloul, N. Bitar, A. Dandashi, J.Abbas, and M. Khalifeh. 2002. A Clinical phase II study of cisplatin and vinorelbine (PVn) in advanced breast carcinoma (ABC). Oral presentation, XII International Congress on Anti-Cancer Treatment, Paris.

Shamseddine, A., A. Taher, S. Fakhani, M. Zhang, CR Scott, and Z. Habbal. 2002. Gaucher disease Type 1, a novel mutation in a Lebanese family. XVI Meeting of the International Society of Haematology, Cairo. (Poster-PF 35/9)

Sibai, A., A. Shamseddine, N. Gehchan, B. Rahal, N. El Saghir, M. Ghosn, G.Aftimos, N. Chamseddine, and M. Seoud. 2003. Cancer incidence in post war Lebanon: The first population-based estimates, 1993–1998. Proceeding of American Society of Clinical Oncology (ASCO) 22: Abstract 2239.

Taher, A., I. Khalil, A. Shamseddine, F. El Ahdab, Z. El Khatib, and A. Bazarbachi. Jan 2002. High prevelance of factor V leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is Eastern Mediterranean region the primary focus of the mutation? XVI Meeting of the International Society of Haematology, Cairo. (Oral – OF 9/7)

Taher, A., F. H. Mourad, A. Shamseddine, M. Sheikh Taha, S. Koussa, A. Inati, Z.A El Khatib, and A.V Hoffbrand. Jan 2002. Comparison between desferrioxamine, deferiprone and a combination therapy in iron overloaded thalassemia patients. XVI Meeting of the International Society of Haematology, Cairo. (Oral – OF 13/3)

Taher, A., F. H. Mourad, M. Sheikh-Taha, S. Koussa, A. Inati, R. Neeman, and A. V. Hoffbrand. 2001. Comparison between desferrioxamine, deferiprone and a combination therapy in iron overloaded thalassemia patients. SOSTE Notiziario 2001; 2:144.

Uthman, I. 2001. Experience with remicade at the AUB-MC. 5^th Pan-Arab Rheumatology Congress, Damascus, Syria.

. 2002. HLA typing in Lebanese Behcet patients. 33rd Laurentian Conference of Rheumatology, Mont Tremblant, Quebec, Canada.

. 2002. Treatment of refractory posterior vitritis in Behçet disease with infliximab. 66th Annual meeting of the American College of Rheumatology, New Orleans, Louisiana, United States.

. 2003. Clinical experience with the use of infliximab in an academic rheumatology practice. 6^th Pan-Arab Rheumatology Congress, Beirut, Lebanon.

Uthman, I., T. Arayssi, R. Hamra, S. Awwad, I. Kazma, F. Homaidan, and Z. Bashour. 2003. Treatment of refractory posterior vitritis in Behçet disease with infliximab. Proceedings of the Annual meeting of the Canadian Rheumatology Association. Mont Tremblant, Quebec, Canada.

Uthman, I., A. Muffarij, W. Mudawar, F. Nasr, and A. F. Masri. 2001. The clinicopathological characteristics of lupus nephritis in Lebanon. Proceedings of the Annual meeting of the Canadian Rheumatology Association. Mont tremblant, Quebec, Canada.

other activities

Arnaout, S. 2001. Invasive and non-invasive modalities in diagnosis and treatment of CAD. Interview on “ART International.”

. 2001. Smoking, side effect and sessation. Interview in the Health morning program, A National Health Program, on NBN Television.

. 2002. Cardiovascular risk factors. Lessons from epidemiological studies. Invited speaker by the Lebanese Order of Physicians and Lebanese Society of General Practice, Zahle, Bekaa, June 8, 2002.

. 2002. Dyslipidaemia and atherosclerosis. Invited speaker by Astra Zeneca group, Crowne Plaza, Dubai.

. 2002. Non invasive modalities in detecting myocardial ischemia. Invited speaker by the Lebanese Society of Cardiology, Movenpick Hotel, Beirut, Lebanon, July 13, 2002.

. 2002. The Management of hypertension in the new millennium: Blood pressure control and beyond. Invited speaker by the Lebanese Order of Physicians and Lebanese Society of General Practice, April, 28, 2002.

. 2002. Invited speaker by the Lebanese Order of Physicians and Lebanese Society of General Practice at two days meeting on Cardiovascular Disease Prevention in General Practice. Zahle, Bekaa, June 9, 2002.

. 2002. Moderator and chairman on the Echocardiography session. IV international Congress of Cardiology and Cardiac Surgery, Beirut, Lebanon, October 23–26, 2002.

. 2003. Calcium Channel blockers still a valid treatment for Hypertension. Invited speaker, Abu-Duhbi, May 11, 2003.

. 2003. Echocardiographic findings in systolic and diastolic heart failure. Invited speaker by the Lebanese Society of Cardiology and Cardiac Surgery, Sidon, Lebanon, May 3, 2003.

. 2003. Pharmacotherapy for critical limb ischemia. Invited speaker by the Committee of the Lebanses Order of Physician and C.M.E Committee and Said Govermental Hospital, Khan El Franj, Saida, Lebanon, January 11, 2003.

. 2003. The role of calcium channel blockers in the treatment of hypertension, the place of long acting dihydropyridine. Invited speaker, Le Meridien, Dubai, May-10, 2003.

Bazarbachi, A. 2001. Treatment of adult T cell leukemia/lymphoma: Current strategy and future perspectives. Lecture presented at the 10^th International Conference on Human Retrovirology: HTLV and related viruses, Plenary session, Dublin, Ireland.

. 2003. Advances in lymphoma therapy. Special Saudi Arabia Oncology Workshop, Jeddah, Saudi Arabia.

Birbari, A. 2001. Diabetic nephropathy. Guest lecturer at the Department of Internal Medicine, Shiraz University, Iran, Nov 5–8, 2001.

. 2001. Hypertension treatment in the new millennium. Guest lecturer at the Iranian Association for Physiologists and Pharmacologists, Iran, Nov 5–8, 2001.

. 2002. Evaluation and management of hypertension in clinical practice. Lecture tour, Sana’a, Yamen, July 12, 2002.

. 2002. Hypertension and obesity in the Eastern Mediterranean region: Prevalence, causes, and recommendations for actions. Invited speaker, WHL/NHLBI Hypertension/Obesity Project Symposium, April 10, 2002.

graduate theses and projects

Abi Samra, A. 2001–02. Bone metabolism in hyper- and normo- insulinemic obese subjects. G. El-Hajj Fuleihan.

Bou Rashed, N. Effect of experimental colitis on water movement across the rat jejunum: Putative role for NO and VIP. F. Mourad and K. Barada.

Skoury, M. 2002–2003. Regulation of the PEPT1 symporter in insulin-treated diabetic rats. A. Sharara.